US5668255A
(en)
|
1984-06-07 |
1997-09-16 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
WO1993024632A1
(en)
|
1992-05-22 |
1993-12-09 |
Dana Farber Cancer Institute |
Hybrid siv/hiv-1 viral vectors and monkey model for aids
|
US5674703A
(en)
|
1992-12-02 |
1997-10-07 |
Woo; Savio L. C. |
Episomal vector systems and related methods
|
WO1995002697A1
(fr)
|
1993-07-13 |
1995-01-26 |
Rhone-Poulenc Rorer S.A. |
Vecteurs adenoviraux defectifs et utilisation en therapie genique
|
CA2265460A1
(en)
|
1996-09-11 |
1998-03-19 |
The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services |
Aav4 vector and uses thereof
|
AU8828598A
(en)
|
1997-08-15 |
1999-03-08 |
Rubicon Laboratory, Inc. |
Retrovirus and viral vectors
|
AU1124499A
(en)
|
1997-10-28 |
1999-05-17 |
Maxygen, Inc. |
Human papillomavirus vectors
|
WO1999047691A1
(en)
|
1998-03-20 |
1999-09-23 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
ES2323744T3
(es)
|
1998-10-01 |
2009-07-23 |
University Of Southern California |
Sistema retroviral de suministro de genes y metodos de uso.
|
US6156514A
(en)
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
US6410013B1
(en)
|
1999-01-25 |
2002-06-25 |
Musc Foundation For Research Development |
Viral vectors for use in monitoring HIV drug resistance
|
WO2000072886A1
(en)
|
1999-05-26 |
2000-12-07 |
Dana-Farber Cancer Institute, Inc. |
Episomally replicating lentiviral vectors
|
AU2001257611A1
(en)
|
2000-04-28 |
2001-11-12 |
Avigen, Inc. |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
US20040214158A1
(en)
|
2000-05-12 |
2004-10-28 |
Neerja Sethi |
Treatment of human papillomavirus (hpv)-infected cells
|
AU2001265187A1
(en)
*
|
2000-05-30 |
2001-12-11 |
Baylor College Of Medicine |
Chimeric viral vectors for gene therapy
|
NO314588B1
(no)
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
|
US7122181B2
(en)
*
|
2000-12-19 |
2006-10-17 |
Research Development Foundation |
Lentiviral vector-mediated gene transfer and uses thereof
|
US20030119770A1
(en)
|
2001-08-02 |
2003-06-26 |
Zhennan Lai |
Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors
|
AU2002323270A1
(en)
|
2001-08-18 |
2003-03-03 |
Myriad Genetics, Inc |
Composition and method for treating hiv infection
|
US7737124B2
(en)
|
2001-09-13 |
2010-06-15 |
California Institute Of Technology |
Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
|
EP1446158B1
(en)
|
2001-10-25 |
2010-07-07 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Efficient inhibition of hiv-1 viral entry through a novel fusion protein including cd4
|
US20070203333A1
(en)
|
2001-11-30 |
2007-08-30 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
EP1495141A4
(en)
|
2002-03-20 |
2006-03-22 |
Massachusetts Inst Technology |
HIV THERAPEUTIC
|
US20040142416A1
(en)
|
2002-04-30 |
2004-07-22 |
Laipis Philip J. |
Treatment for phenylketonuria
|
BR0308896A
(pt)
|
2002-05-07 |
2007-01-09 |
Chiron Corp |
complexos e hìbridos envelope do hiv-cd4
|
US7199107B2
(en)
|
2002-05-23 |
2007-04-03 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of kinesin-like 1 expression
|
US20040161412A1
(en)
|
2002-08-22 |
2004-08-19 |
The Cleveland Clinic Foundation |
Cell-based VEGF delivery
|
WO2004021995A2
(en)
|
2002-09-06 |
2004-03-18 |
The Government Of The United States Of America, Represented By The Secretary, Departement Of Health And Human Services |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
|
ES2334125T3
(es)
|
2002-11-04 |
2010-03-05 |
University Of Massachusetts |
Interferencia de arn especifico de alelos.
|
AU2003283174A1
(en)
|
2002-12-11 |
2004-06-30 |
Cytos Biotechnology Ag |
Method for protein production
|
WO2004104591A2
(en)
*
|
2003-05-23 |
2004-12-02 |
Institut National De La Sante Et De La Recherche Medicale |
Improvements to gamma delta t cell-mediated therapy
|
WO2005005644A1
(en)
|
2003-07-11 |
2005-01-20 |
Cytos Biotechnology Ag |
Gene expression system
|
US20050019927A1
(en)
|
2003-07-13 |
2005-01-27 |
Markus Hildinger |
DECREASING GENE EXPRESSION IN A MAMMALIAN SUBJECT IN VIVO VIA AAV-MEDIATED RNAi EXPRESSION CASSETTE TRANSFER
|
US20050138677A1
(en)
|
2003-09-16 |
2005-06-23 |
Pfister Herbert J. |
Transgenic animal model for the treatment of skin tumors
|
EP1678292A4
(en)
|
2003-09-18 |
2008-05-07 |
Univ Emory |
IMPROVED MVA VACCINES
|
WO2005033282A2
(en)
|
2003-10-01 |
2005-04-14 |
Pharmacia & Upjohn Company Llc |
Polyamide compositions and therapeutic methods for treatment of human papilloma virus
|
US20080039413A1
(en)
|
2003-10-21 |
2008-02-14 |
Morris David W |
Novel compositions and methods in cancer
|
EP1753777B1
(en)
|
2004-02-25 |
2014-05-07 |
Dana-Farber Cancer Institute, Inc. |
METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION USING TRIM5a
|
WO2005085443A2
(en)
|
2004-03-01 |
2005-09-15 |
Massachusetts Institute Of Technology |
Rnai-based therapeutics for allergic rhinitis and asthma
|
TW201705980A
(zh)
|
2004-04-09 |
2017-02-16 |
艾伯維生物技術有限責任公司 |
用於治療TNFα相關失調症之多重可變劑量療法
|
US20080227736A1
(en)
|
2004-06-03 |
2008-09-18 |
Regents Of The University Of California, |
Targeting Pseudotyped Retroviral Vectors
|
US20080131940A1
(en)
|
2004-06-25 |
2008-06-05 |
Robert Chiu |
Target Cell-Specific Short Interfering Rna and Methods of Use Thereof
|
EP1789447B1
(en)
|
2004-08-16 |
2012-04-25 |
Immune Disease Institute, Inc. |
Method of delivering rna interference and uses thereof
|
EP1802641B8
(en)
|
2004-10-08 |
2012-03-07 |
The Board Of Trustees Of The University Of Illinois |
Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
|
EP1647595A1
(en)
|
2004-10-15 |
2006-04-19 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Nucleic acids against viruses, in particular HIV
|
CA2585523A1
(en)
|
2004-11-02 |
2006-05-11 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Adenoviral amplicon and producer cells for the production of replication-defective adenoviral vectors, methods of preparation and use thereof
|
US7790446B2
(en)
|
2005-02-11 |
2010-09-07 |
Kosagen Cell Factory Oü |
Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
|
US20080254008A1
(en)
*
|
2005-02-16 |
2008-10-16 |
Boro Dropulic |
Lentiviral Vectors and Their Use
|
CA2609142C
(en)
|
2005-05-27 |
2016-02-09 |
Fondazione Centro San Raffaele Del Monte Tabor |
Therapeutic gene vectors comprising mirna target sequences
|
US20070032443A1
(en)
*
|
2005-08-02 |
2007-02-08 |
Jaeseob Kim |
Therapy for Alzheimer's disease
|
WO2007015122A1
(en)
*
|
2005-08-02 |
2007-02-08 |
Genexel, Inc. |
Therapy for alzheimer’s disease
|
US20070105835A1
(en)
|
2005-11-07 |
2007-05-10 |
Kazantsev Aleksey G |
Compositions and methods for modulating poly(ADP-ribose) polymerase activity
|
WO2007133674A2
(en)
|
2006-05-12 |
2007-11-22 |
Lentigen Corporation |
Lentiviral vector compositions, methods and applications
|
WO2007149476A2
(en)
*
|
2006-06-19 |
2007-12-27 |
Trustees Of Columbia University In The City Of New York |
Assays for non-apoptotic cell death and uses thereof
|
US20080003225A1
(en)
|
2006-06-29 |
2008-01-03 |
Henri Vie |
Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors
|
US8124752B2
(en)
|
2006-07-10 |
2012-02-28 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the MYC gene
|
EP1878440A1
(en)
|
2006-07-13 |
2008-01-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds
|
EP2049103A2
(en)
*
|
2006-07-26 |
2009-04-22 |
Novartis AG |
Inhibitors of undecaprenyl pyrophosphate synthase
|
US20080199961A1
(en)
*
|
2006-08-25 |
2008-08-21 |
Avi Biopharma, Inc. |
ANTISENSE COMPOSITION AND METHOD FOR INHIBITION OF miRNA BIOGENESIS
|
EP2415783B1
(en)
*
|
2006-10-16 |
2016-12-14 |
Genelux Corporation |
Modified vaccinia virus strains for use in a diagnostic and therapeutic method
|
US8338101B2
(en)
|
2007-01-23 |
2012-12-25 |
Virco Bvba |
Method for designing a drug regime for HIV-infected patients
|
CA2682694A1
(en)
*
|
2007-04-12 |
2008-10-23 |
The Board Of Trustees Of The University Of Illinois |
Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
|
US20080293142A1
(en)
|
2007-04-19 |
2008-11-27 |
The Board Of Regents For Oklahoma State University |
Multiple shRNA Expression Vectors and Methods of Construction
|
EP2008656A1
(en)
|
2007-06-28 |
2008-12-31 |
Bergen Teknologioverforing AS |
Compositions for the treatment of hyperphenylalaninemia
|
WO2009026328A2
(en)
|
2007-08-21 |
2009-02-26 |
Immune Disease Institute, Inc. |
Methods of delivery of agents to leukocytes and endothelial cells
|
EP2783692B1
(en)
|
2007-09-28 |
2019-01-02 |
Celularity, Inc. |
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
|
EP2090659A1
(en)
|
2008-02-14 |
2009-08-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Infectious particle, process for its preparation and use thereof
|
GB0810209D0
(en)
|
2008-06-04 |
2008-07-09 |
Cambridge Entpr Ltd |
Pluripotency associated epigenetic factor
|
EP2301105A4
(en)
|
2008-06-16 |
2013-06-19 |
Polyplus Battery Co Inc |
AQUEOUS LITHIUM / AIR BATTERIES
|
US8629334B2
(en)
|
2008-07-16 |
2014-01-14 |
University Of Florida Research Foundation, Inc. |
Viral-based transient-expression vector system for trees
|
WO2010022195A2
(en)
|
2008-08-20 |
2010-02-25 |
Virxsys Corporation |
Non-integrating lenti/adeno-associated virus hybrid vector system
|
WO2010033722A2
(en)
|
2008-09-17 |
2010-03-25 |
Isogenis, Inc. |
Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
|
US20100183558A1
(en)
|
2008-10-17 |
2010-07-22 |
Zhennan Lai |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
WO2010051521A1
(en)
|
2008-10-31 |
2010-05-06 |
Lentigen Corporation |
Cell therapy product for the treatment of hiv infection
|
AU2009308707A1
(en)
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
LIGHT targeting molecules and uses thereof
|
CN102369288A
(zh)
|
2008-11-14 |
2012-03-07 |
生命技术公司 |
用于工程化细胞的组合物和方法
|
EP2191834A1
(en)
|
2008-11-26 |
2010-06-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Compositions and methods for treating retrovirus infections
|
AU2010229872A1
(en)
|
2009-03-26 |
2011-11-03 |
The Regents Of The University Of California |
Mesenchymal stem cells producing inhibitory RNA for disease modification
|
US20120034197A1
(en)
|
2009-04-09 |
2012-02-09 |
Stemcyte Inc. |
Hiv-resistant stem cells and uses thereof
|
EP2419113B1
(en)
|
2009-04-13 |
2017-05-10 |
Apceth GmbH & Co. KG |
Engineered mesenchymal stem cells and method of using same to treat tumors
|
EP2425001A4
(en)
|
2009-04-30 |
2012-11-14 |
Univ California |
ANTI-HIV COMBINATION VECTORS, TARGETING VECTORS AND METHOD OF USE
|
ES2546663T3
(es)
|
2009-07-15 |
2015-09-25 |
Calimmune Inc. |
Vector dual para la inhibición del virus de la inmunodeficiencia humana
|
WO2011066578A1
(en)
*
|
2009-11-30 |
2011-06-03 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer
|
CN101805750B
(zh)
*
|
2009-12-29 |
2011-11-30 |
浙江大学 |
法呢基焦磷酸合成酶rna干扰重组慢病毒载体构建及用途
|
CN102782136A
(zh)
|
2010-02-18 |
2012-11-14 |
爱默蕾大学 |
表达hiv抗原和gm-csf的载体和用于产生免疫应答的相关方法
|
WO2011119942A1
(en)
|
2010-03-25 |
2011-09-29 |
Vistagen Therapeutics, Inc. |
Induction of ips cells using transient episomal vectors
|
US20130090371A1
(en)
*
|
2010-04-20 |
2013-04-11 |
President And Fellows Of Harvard College |
Methods and compositions for inhibition of beta2-adrenergic receptor degradation
|
ES2699630T3
(es)
|
2010-04-23 |
2019-02-12 |
Cold Spring Harbor Laboratory |
Novedosos ARNhc diseñados estructuralmente
|
JP5965392B2
(ja)
*
|
2010-05-28 |
2016-08-03 |
オックスフォード バイオメディカ (ユーケー) リミテッド |
脳へのレンチウイルスベクターの送達
|
JP5805089B2
(ja)
|
2010-08-10 |
2015-11-04 |
タカラバイオ株式会社 |
細胞集団の製造方法
|
US20130281493A1
(en)
|
2010-10-07 |
2013-10-24 |
The Trustees Of The University Of Columbia In The City Of New York |
Method for Treating Cancer Harboring a p53 Mutation
|
WO2012061075A2
(en)
|
2010-10-25 |
2012-05-10 |
The Regents Of The University Of California |
Hiv resistant and functional hematopoietic stem/progenitor cells and macrophages from induced pluripotent stem cells
|
CN108744262A
(zh)
|
2010-11-23 |
2018-11-06 |
普莱萨格生命科学公司 |
用于实体递送的治疗方法和组合物
|
CN103492574B
(zh)
|
2011-02-22 |
2015-12-09 |
加州理工学院 |
使用腺相关病毒(aav)载体递送蛋白
|
EP3318635A1
(en)
*
|
2011-04-21 |
2018-05-09 |
University of Massachusetts |
Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
WO2013056148A2
(en)
|
2011-10-15 |
2013-04-18 |
Genentech, Inc. |
Methods of using scd1 antagonists
|
US10640785B2
(en)
|
2011-11-22 |
2020-05-05 |
The Children's Hospital Of Philadelphia |
Virus vectors for highly efficient transgene delivery
|
US9745631B2
(en)
*
|
2011-12-20 |
2017-08-29 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
CA2863964C
(en)
|
2012-02-07 |
2021-10-26 |
Global Bio Therapeutics Usa, Inc. |
Compartmentalized method of nucleic acid delivery and compositions and uses thereof
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
JP2015520179A
(ja)
|
2012-06-06 |
2015-07-16 |
ビオノール イミュノ エーエスBionor Immuno As |
ワクチン
|
US9556433B2
(en)
|
2012-07-17 |
2017-01-31 |
Université De Genève |
Nucleic acids for down-regulation of gene expression
|
US10233495B2
(en)
|
2012-09-27 |
2019-03-19 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
JP6391582B2
(ja)
|
2012-11-13 |
2018-09-19 |
コディアック バイオサイエンシズ インコーポレイテッド |
治療剤の送達方法
|
JP2016500254A
(ja)
|
2012-12-05 |
2016-01-12 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
代謝疾患の調節のための方法および組成物
|
US9642921B2
(en)
|
2012-12-20 |
2017-05-09 |
Tocagen Inc. |
Cancer combination therapy and recombinant vectors
|
WO2014117050A2
(en)
|
2013-01-26 |
2014-07-31 |
Mirimus, Inc. |
Modified mirna as a scaffold for shrna
|
CN103184224A
(zh)
|
2013-04-03 |
2013-07-03 |
衡阳师范学院 |
一种抗艾滋病病毒感染的三联miRNA及构建方法
|
US10501803B2
(en)
|
2013-05-21 |
2019-12-10 |
Max-Planck Gesellschaft zur Förderung der Wissenschaften e.V. |
Isoforms of GATA6 and NKX2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy
|
CN105683383B
(zh)
|
2013-06-03 |
2020-08-21 |
赛拉福柯蒂斯公司 |
含有I型MHC、II型MHC或β2微球蛋白上游启动子序列的慢病毒载体
|
CA2954168C
(en)
|
2013-08-02 |
2023-09-19 |
The Regents Of The University Of California |
Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors
|
WO2015042308A2
(en)
|
2013-09-18 |
2015-03-26 |
City Of Hope |
Rna-based hiv inhibitors
|
CN105658242A
(zh)
|
2013-10-22 |
2016-06-08 |
夏尔人类遗传性治疗公司 |
用于苯丙酮尿症的mrna疗法
|
AU2014346559B2
(en)
|
2013-11-07 |
2020-07-09 |
Editas Medicine,Inc. |
CRISPR-related methods and compositions with governing gRNAs
|
EP2878674A1
(en)
|
2013-11-28 |
2015-06-03 |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) |
Stable episomes based on non-integrative lentiviral vectors
|
CA2944199C
(en)
|
2014-03-28 |
2023-08-15 |
Regents Of The University Of Minnesota |
Polypeptides, cells, and methods involving engineered cd16
|
US11400115B2
(en)
|
2014-04-23 |
2022-08-02 |
Juno Therapeutics, Inc. |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
CN114395559A
(zh)
|
2014-04-25 |
2022-04-26 |
吉尼松公司 |
高胆红素血症的治疗
|
SI3134432T1
(sl)
*
|
2014-04-25 |
2021-01-29 |
Bluebird Bio, Inc. |
MND promotor himernega antigenskega receptorja
|
EP3186365A4
(en)
|
2014-08-29 |
2018-04-25 |
Immunomedics, Inc. |
Identification of cancer genes by in-vivo fusion of human cancer cells and animal cells
|
DK3197472T3
(da)
|
2014-09-22 |
2021-10-18 |
Tanea Medical Ab |
Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
|
AU2015329696A1
(en)
|
2014-10-10 |
2017-04-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods to eliminate cancer stem cells by targeting CD47
|
CN107405357B
(zh)
|
2014-10-14 |
2021-12-31 |
德克萨斯科技大学系统 |
多重shRNAs及其应用
|
WO2016069716A1
(en)
|
2014-10-30 |
2016-05-06 |
The Scripps Research Institute |
Compositions and methods comprising tyrosyl-trna synthetases and resveratrol compounds
|
GB201509202D0
(en)
|
2015-05-28 |
2015-07-15 |
Ge Healthcare Bio Sciences Ab |
Semi-static cell culture
|
JP6924487B2
(ja)
|
2015-06-10 |
2021-08-25 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
非組み込みウイルス送達システムおよびその使用の方法
|
US20180177866A1
(en)
|
2015-07-08 |
2018-06-28 |
American Gene Technologies International, Inc. |
Hiv pre-immunization and immunotherapy
|
KR102142364B1
(ko)
|
2015-08-13 |
2020-08-07 |
베이하오 스템 셀 앤 리제너레이티브 메디슨 리서치 인스티 튜트 씨오.,엘티디. |
유도 연장 만능 줄기 세포, 이의 제조방법 및 사용 방법
|
CN105112370B
(zh)
*
|
2015-08-25 |
2019-02-05 |
杭州优善生物科技有限公司 |
一种体外刺激外周血γδT细胞高效增殖的方法及其应用
|
JP7059179B2
(ja)
|
2015-10-20 |
2022-04-25 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
遺伝子操作のための方法及び製品
|
WO2017100551A1
(en)
|
2015-12-09 |
2017-06-15 |
Alexion Pharmaceuticals, Inc. |
HETEROLOGOUS UTR SEQUENCES FOR ENHANCED mRNA EXPRESSION
|
EP4310500A3
(en)
|
2016-01-15 |
2024-04-03 |
American Gene Technologies International Inc. |
Methods and compositons for the activation of gamma-delta t-cells
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
WO2017139065A1
(en)
|
2016-02-08 |
2017-08-17 |
American Gene Technologies International Inc. |
Hiv vaccination and immunotherapy
|
US10767183B2
(en)
|
2016-03-09 |
2020-09-08 |
American Gene Technologies International Inc. |
Combination vectors and methods for treating cancer
|
SG11201807223UA
(en)
|
2016-03-23 |
2018-09-27 |
Univ Columbia |
CANCER TREATMENT BASED ON DELIVERY OF OLIGOES VIA GAP JUNCTIONS FROM HUMAN MESENCHYMAL STEM CELLS (hMSC)
|
WO2017173453A1
(en)
|
2016-04-01 |
2017-10-05 |
The Brigham And Women's Hospital, Inc. |
Stimuli-responsive nanoparticles for biomedical applications
|
US20190264226A1
(en)
|
2016-06-08 |
2019-08-29 |
American Gene Technologies International Inc. |
Non-integrating viral delivery system and methods related thereto
|
AU2017292582C1
(en)
|
2016-07-08 |
2021-11-11 |
American Gene Technologies International Inc. |
HIV pre-immunization and immunotherapy
|
WO2018017882A1
(en)
|
2016-07-21 |
2018-01-25 |
American Gene Technologies International Inc. |
Viral vectors for treating parkinson's disease
|
CN110325199A
(zh)
|
2016-12-30 |
2019-10-11 |
宾夕法尼亚州立大学托管会 |
用于治疗苯丙酮尿症的基因疗法
|
EP3565564A4
(en)
|
2017-01-09 |
2020-09-23 |
American Gene Technologies International Inc. |
HIV IMMUNOTHERAPY WITHOUT PRE-IMMUNIZATION STEP
|
CN110621322A
(zh)
|
2017-02-08 |
2019-12-27 |
达纳-法伯癌症研究所有限公司 |
用异双功能性化合物进行的可调节的内源性蛋白质降解
|
SG10201912969XA
(en)
*
|
2017-02-28 |
2020-02-27 |
Univ Pennsylvania |
Adeno-associated virus (aav) clade f vector and uses therefor
|
JP2020512815A
(ja)
|
2017-04-03 |
2020-04-30 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
フェニルケトン尿症を処置するための組成物および方法
|
US20200181645A1
(en)
|
2017-06-16 |
2020-06-11 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells
|
US20200318081A1
(en)
|
2017-10-02 |
2020-10-08 |
American Gene Technologies International Inc. |
Vectors with promoter and enhancer combinations for treating phenylketonuria
|
DE112019000348B4
(de)
|
2018-01-05 |
2021-10-28 |
Nantbio, Inc. |
Umprogrammierte t-zellen ähnliche nk-zellen
|
EP3820888A4
(en)
|
2018-07-13 |
2022-04-27 |
Nanjing Legend Biotech Co., Ltd. |
CO-RECEPTOR SYSTEMS FOR THE TREATMENT OF INFECTIOUS DISEASES
|
JP2022506515A
(ja)
|
2018-11-05 |
2022-01-17 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
制御性rnaを発現させるためのベクターシステム
|
AU2020283069A1
(en)
|
2019-05-31 |
2022-01-06 |
American Gene Technologies International Inc. |
Optimized phenylalanine hydroxylase expression
|
CA3170630A1
(en)
|
2020-03-03 |
2021-09-10 |
American Gene Technologies International Inc. |
On demand expression of exogenous factors in lymphocytes to treat hiv
|